Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prescreening Study to Diagnose Allergic Bronchopulmonary Aspergillosis in Selected Patients With Asthma

NCT05903612 is registered in ClinicalTrials.gov with Community Pharmacology Services Ltd as lead sponsor.

NCT NCT05903612
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05903612 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prescreening Study to Diagnose Allergic Bronchopulmonary Aspergillosis in Selected Patients With Asthma
Lead sponsor
Community Pharmacology Services Ltd
Phase
Observational
Overall status
Withdrawn
Start date
January 10, 2024
Completion date
January 10, 2024
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abpa, allergic bronchopulmonary aspergillosis, asthma